Legal Representation
Attorney
Jason Sanders
USPTO Deadlines
Next Deadline
1700 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-03-05)
Due Date
March 05, 2030
Grace Period Ends
September 05, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
50 events| Date | Code | Type | Description |
|---|---|---|---|
| Mar 5, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Mar 5, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Jan 27, 2024 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Jan 26, 2024 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Jan 6, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jan 5, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Jan 5, 2024 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
| Jan 3, 2024 | PROA | I | TEAS PETITION TO REVIVE RECEIVED |
| Jan 3, 2024 | PETG | O | PETITION TO REVIVE-GRANTED |
| Jan 3, 2024 | NREV | E | NOTICE OF REVIVAL - E-MAILED |
| Jan 3, 2024 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION |
| Jan 3, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
| Jan 3, 2024 | NREV | E | NOTICE OF REVIVAL - E-MAILED |
| Jan 3, 2024 | IUAF | S | USE AMENDMENT FILED |
| Dec 28, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Dec 28, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Dec 28, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Dec 20, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Dec 20, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Dec 20, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Dec 20, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Dec 20, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Dec 20, 2023 | EXT2 | S | SOU EXTENSION 2 FILED |
| Jul 1, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jun 30, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Jun 20, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Jun 13, 2023 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED |
| Jun 13, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jun 13, 2023 | EXT1 | S | SOU EXTENSION 1 FILED |
| Dec 20, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Oct 25, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Oct 25, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Oct 5, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Sep 19, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Aug 29, 2022 | ALIE | A | ASSIGNED TO LIE |
| Aug 29, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Aug 29, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Aug 19, 2022 | PROA | I | TEAS PETITION TO REVIVE RECEIVED |
| Aug 19, 2022 | PETG | O | PETITION TO REVIVE-GRANTED |
| Aug 19, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Aug 19, 2022 | NREV | E | NOTICE OF REVIVAL - E-MAILED |
| Feb 18, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Feb 18, 2022 | GNRT | O | NON-FINAL ACTION E-MAILED |
| Feb 18, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Jan 26, 2022 | ALIE | A | ASSIGNED TO LIE |
| Jan 26, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jan 26, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jan 17, 2022 | ALIE | A | ASSIGNED TO LIE |
| Jan 13, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Oct 20, 2021 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Detailed Classifications
Class 001
Reagents, cartridges and testing kits comprised of diagnostic reagents and assays for testing cell gene expression and cell data for scientific and research purposes; testing kits, namely, chemical preparations, compounds, enzymes, and fluids sold together as a unit for scientific and research purposes
First Use Anywhere:
Jan 18, 2022
First Use in Commerce:
Jan 18, 2022
Class 005
Reagents, cartridges and testing kits comprised of medical diagnostic reagents and assays for testing cell gene expression and cell data for medical diagnostic use; Testing kits, namely, chemical preparations, compounds, enzymes, and fluids sold together as a unit for medical diagnostic purposes
First Use Anywhere:
Jan 18, 2022
First Use in Commerce:
Jan 18, 2022
Class 009
Scientific equipment, namely, devices for analyzing nucleic acids, for RNA and DNA analysis, and for DNA sequencing for the purpose of performing scientific research, and downloadable software for use therewith sold as a unit; medical diagnostic apparatus for high-speed analysis for assessing cells for the purpose of performing scientific research
First Use Anywhere:
May 8, 2020
First Use in Commerce:
May 8, 2020
Class 010
Medical equipment, namely, devices for analyzing nucleic acids, for RNA and DNA analysis, and for DNA sequencing for the purpose of providing medical treatment and diagnosis, and downloadable software for use therewith sold as a unit; medical diagnostic apparatus for high-speed analysis for assessing cells for the purpose of providing medical treatment and diagnosis
First Use Anywhere:
May 8, 2020
First Use in Commerce:
May 8, 2020
Class 042
Scientific and laboratory research, development, consulting, design, engineering and testing services in the fields of biotechnology, pharmaceuticals, computer science, chemistry, biochemistry, biology, genetics, genotyping and forensic sciences; Scientific research featuring the analysis, detection and isolation of biological substances in samples in the fields of genetics, genotyping, DNA analysis and pharmacogenetics
First Use Anywhere:
Oct 1, 2017
First Use in Commerce:
Oct 1, 2017
Additional Information
Design Mark
The mark consists of the stylized mark "LEVITASBIO" where stylized rectangular shapes make up the letter "E" and stylized circular shapes make up the letter "A".
Pseudo Mark
LEVITAS BIO
Classification
International Classes
001
005
009
010
042